Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Ascendis Pharma Ads (ASND)

27.71 +2.60 (+10.35%)

6/28/2017  4:00pm

Open:

25.20

Pre. Close:

25.11

High:

27.72

Low:

25.20

Volume:

58,156

Market Cap:

900.63M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

28.22 - 28.51

28.51 - 28.85

Low:

24.31 - 24.63

24.63 - 25

Close:

27.37 - 27.86

27.86 - 28.42

Technical analysis  (as of: 2017-06-28 4:33:26 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 32.66     One year: 38.14

Support:

Support1: 24.25    Support2: 21.95

Resistance:

Resistance1: 27.96    Resistance2: 32.66

Pivot:

24.24

Moving Averages:

MA(5): 25.65     MA(20): 24.17

MA(100): 26.90     MA(250): 21.89

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.62

%K %D:

%K(14,3): 78.15     %D(3): 70.42

RSI:

RSI(14): 63.33

52-Week:

High: 31.86  Low: 12.34  Change(%): 106.9

Average Vol(K):

3-Month: 99  10-Days 315

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ASND has closed above the upper band by 11.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 50.7% wider than normal. The large width of the bands suggest high volatility as compared to ASND's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Thu, 23 Mar 2017 13:04:20 GMT
Ascendis Pharma A/S Announces Conference Call and Webcast to Review Data at ...

Tue, 28 Feb 2017 21:45:00 GMT
Ascendis Pharma A/S Announces Multiple Poster Presentations at ENDO 2017

Tue, 23 May 2017 20:03:36 GMT
Ascendis Pharma A/S Reports First Quarter 2017 Financial Results

Tue, 23 May 2017 20:26:15 GMT
BRIEF-Ascendis Pharma A/S Q1 loss per share eur 0.78

Fri, 10 Mar 2017 12:56:15 GMT
Ascendis Pharma A/S Announces Year-End 2016 Financial Results Conference Call ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

32.50

Shares Float (M)

10.98

% Held by Insiders

6.85

% Held by Institutions

36.80

Shares Short (K)

337

Shares Short Prior Month (K)

342

Stock Financials

EPS

-2.870

EPS Est. Current Year

-3.420

EPS Est. Next Year

-3.220

EPS Est. Next Quarter

-0.820

Forward EPS

1.#IO

Book Value (p.s.)

5.200

PEG Ratio

Profit Margin

Operating Margin

-2112.61

Return on Assets (ttm)

-34.4

Return on Equity (ttm)

-57.0

Qtrly Rev. Growth

-70.4

Gross Profit (p.s.)

0.150

Sales Per Share

EBITDA (p.s.)

-2.663

Qtrly Earnings Growth

Operating Cash Flow (M)

-73.94

Levered Free Cash Flow (M)

-42.59

FoxReading.com

Valuation

P/E

-9.66

P/E Growth Ratio

0.10

P/BV

5.33

P/S

6003833344.00

P/CF

-12.18

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.